Resistance of Acanthamoeba species to complement lysis

Journal of Parasitology

Volumn 84, Issue 2, 1998, Pages 338-344

  Toney, Denise M ^a   Marciano Cabral, Francine ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHAMOEBA; ARTICLE; CELL MEMBRANE RESISTANCE; COMPLEMENT ACTIVATION; CYTOLYSIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; MACROPHAGE ACTIVATION; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; SPECIES DIFFERENCE;

ACANTHAMOEBA; ANIMALS; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; CYCLOHEXIMIDE; CYTOCHALASIN D; HUMANS; MICROSCOPY, ELECTRON; NEURAMINIDASE; NUCLEIC ACID SYNTHESIS INHIBITORS; PEPSTATINS; PHENYLMETHYLSULFONYL FLUORIDE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; PROTEASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; TRYPSIN;

ACANTHAMOEBA; ACANTHAMOEBA CASTELLANII; ACANTHAMOEBA CULBERTSONI; ACANTHAMOEBA POLYPHAGA; PROTOZOA;

EID: 0031976762     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.2307/3284492     Document Type: Article

References (33)

1. BRADLEY, S. G., D. M. TONEY, Y. ZHANG, AND F. MARCIANO-CABRAL. 1996. Dependence of growth, metabolic expression and pathogenicity of Naegleria fowleri on exogenous porphyrins. Infection and Immunity 82: 763-768.
2. BRITTINGHAM, A., C. J. MORRISON, W. R. MCMASTER, B. S. MCGWIRE, K.-P CHANG, AND D. M. MOSSER. 1995. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. Journal of Immunology 155: 3102-3111.
3. CLINE, M., F. MARCIANO-CABRAL, AND S. G. BRADLEY. 1983. Comparisons of Naegleria fowleri and Naegleria gruberi cultivated in the same nutrient medium. Journal of Protozoology 30: 387-391.
4. CULBERTSON, C. G. 1971. The pathogenicity of soil amebas. Annual Reviews in Microbiology 25: 231-254.
5. _, J. W. SMITH, AND J. R. MINNER. 1958. Acanthamoeba: Observations on animal pathogenicity. Science 127: 1506.
6. CURSONS, R. T. M., T. J. BROWN, E. A. KEYS, R. M. MORIARTY, AND D. TILL. 1980. Immunity to pathogenic free-living amoebae: Role of humoral antibody. Infection and Immunity 29: 401-407.
7. ETGES, R., J. BOUVIER, AND C. BORDIER. 1986. The major surface protein of Leishmania promastigotes is a protease. Journal of Biological Chemistry 261: 9098-9101.
8. FERRANTE, A. 1991. Free-living amoebae: Pathogenicity and immunity. Parasite Immunology 13: 31-47.
9. FERRANTE, A., AND B. ROWAN-KELLY. 1983. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni. Clinical Experimental Immunology 54: 477-481.
10. FRIEDLAND, L. R., S. A. RAPHAEL, E. S. DEUTSCH, J. JOHAL, L. J. MARTYN, G. S. VISVESVARA, AND H. W. LISCHNER. 1992. Disseminated Acanthamoeba infection in a child with symptomatic human immunodeficiency virus infection. Pediatric Infectious Disease Journal 11: 404-407.
11. GONZALEZ, M., E. GOULD, G. DICKINSON, A. J. MARTINEZ, G. S. VISVESVARA, T. J. CLEARY, AND G. T. HENSLY. 1986. Acquired immunodeficiency syndrome associated with Acanthamoeba infection and other opportunistic organisms. Archives in Pathology Laboratory Medicine 110: 749-751.
12. GORDON, S. M., J. P. STEINBERG, M. H. DUPUIS, P. E. KOZARSKY, J. F. NICKERSON, AND G. S. VISVESVARA. 1992. Culture isolation of Acanthamoeba species and Leptomyxid amebas from patients with amebic meningoencephalitis, including two patients with AIDS. Clinical Infectious Disease 15: 1024-1030.
13. GULLET, J., J. MILLS, K. HADLEY, B. PODEMSKI, L. PITTS, AND R. GELBER. 1979. Disseminated granulomatous Acanthamoeba infection presenting as an unusual skin lesion. American Journal of Medicine 67: 891-896.
14. JOHN, D. T. 1993. Opportunistically pathogenic free-living amebae. In Parasitic protozoa. 2nd ed., Vol. 3. J. P. Kreier and J. R. Baker (eds.). Academic Press, Inc., San Diego, California, p. 143-246.
15. JOKIRANTA, T. S., L. JOKIPII, AND S. MERI. 1995. Complement resistance of parasites. Scandinavian Journal of Immunology 42: 9-20.
16. KENT, J. F., AND E. H. FIFE. 1963. Precise standardization of reagents for complement fixation. American Journal of Tropical Medicine 12: 103.
17. MARCIANO-CABRAL, F. 1988. The biology of Naegleria spp. Microbiological Reviews 52: 114-133.
18. _, M. PATTERSON, D. T. JOHN, AND S. G. BRADLEY. 1982. Cytopathogenicity of Naegleria fowleri and Naegleria gruben for established mammalian cell cultures. Journal of Parasitology 68: 1110-1116.
19. _, AND D. M. TONEY. 1994. Modulation of biological functions of Naegleria fowleri amoebae by growth medium. Journal of Eukaryotic Microbiology 41: 38-46.
20. MARTINEZ, A. J. 1987. Clinical manifestations of free-living amebic infections. In Amphizoic amebae: Human pathology, E. G. Rondanelli (ed.). Picin, Padua, Italy, p. 161-177.
21. _. 1991. Infection of the central nervous system due to Acanthamoeba. Reviews in Infectious Diseases 13: S399-S402.
22. MORGAN, B. P., AND S. MERI. 1994. Membrane proteins that protect against complement lysis. Springer Seminar in Immunopathology 15: 369-396.
23. NEFF, R. J., S. A. RAY, W. F. BENTON, AND M. WILBORN. 1964. In Methods in cell physiology, Vol. 1, D. M. Prescott (ed.). Academic Press, New York, New York, p. 55.
24. PIGON, A. 1987. Acanthamoeba microexudate: A cell detoxification system. Cytobios 50: 133-144.
25. PILLEMER, L., I. H. LEPOW, AND L. BLUM. 1953. The requirement for a hydrazine-sensitive serum factor and heat-labile serum factors in the inactivation of human C′3 by zymosan. Journal of Immunology 71: 339-345.
26. SCHUSTER, F. L. 1969. Intranuclear virus-like bodies in the amoeboflagellate Naegleria gruberi. Journal of Protozoology 16: 724-727.
27. STEWART, G. L., I. KIM, K. SHUPE, H. ALIZADEH, R. SILVANY, J. P. MCCULLEY, AND J. Y. NIEDERKORN. 1992. Chemotactic response of macrophages to Acanthamoeba castellanii antigen and antibody-dependent macrophage-mediated killing of the parasite. Journal of Parasitology 78: 849-855.
28. TONEY, D. M., AND F. MARCIANO-CABRAL. 1992. Alterations in protein expression and complement resistance of pathogenic Naegleria amoebae. Infection and Immunity 60: 2784-2790.
29. _, AND _. 1994. Modulation of complement resistance and virulence of Naegleria fowleri amoebae by alterations in growth media. Journal of Eukaryotic Microbiology 41: 337-343.
30. VISVESVARA, G. S., D. B. JONES, AND N. ROBINSON. 1975. Isolation, identification and biological characterization of Acanthamoeba polyphaga from a human eye. American Journal of Tropical Medicine and Hygiene 24: 784-790.
31. VOGT, W. 1974. Activation, activities and pharmacologically active products of complement. Pharmacological Reviews 26: 125-169.
32. WHITEMAN, L. Y., AND F. MARCIANO-CABRAL. 1987. Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis. Infection and Immunity 55: 2442-2447.
33. WILEY, C. A., R. E. SAFRIN, C. E. DAVIS. P. W. LAMPERT, A. I. BRAUDE, A. J. MARTINEZ, AND G. S. VISVESVARA. 1987. Acanthamoeba meningoencephalitis in a patient with AIDS. Journal of Infectious Diseases 155: 130-133.